<DOC>
	<DOCNO>NCT00262899</DOCNO>
	<brief_summary>RATIONALE : Genetics education counseling may help patient make treatment decision . It yet know genetic counseling usual care influence patient treatment decision breast cancer . PURPOSE : This randomized clinical trial study well genetic counseling work compare usual care help patient newly diagnose ductal carcinoma situ , stage I , stage II , stage IIIA breast cancer make treatment decision .</brief_summary>
	<brief_title>Genetic Counseling Usual Care Helping Women With Newly Diagnosed Ductal Carcinoma In Situ Stage I , Stage II , Stage IIIA Breast Cancer Make Treatment Decisions</brief_title>
	<detailed_description>OBJECTIVES : - Compare impact rapid genetic counseling ( RGC ) vs usual care medical decision woman newly diagnose ductal carcinoma situ stage I-IIIA breast cancer . - Compare impact intervention quality life psychological well patient . - Determine baseline factor predict least likely benefit RGC patient undergoing intervention . - Compare cost per quality adjust life year save societal perspective patient undergoing intervention . OUTLINE : This randomize , multicenter study . Patients stratify accord participate site . Patients randomize 1 2 interventional arm . - Arm I ( rapid genetic counseling ) : Patients undergo 1Â½ hour genetic counseling session either person telephone . Patients undergo telephone counsel receive booklet visual aid educational material . Patient preference value assess immediately counsel . Some patient may undergo BRCA1/2 status determination . Patients undergo follow-up telephone interview 1 , 6 , 12 month . - Arm II ( usual care ) : Patients receive packet breast cancer treatment educational material . Patient preference value assess 2 week later . Patients undergo follow-up telephone interview arm I . In arm , quality life assess baseline 1 , 6 , 12 month . After completion study , patient follow periodically 1 year . PROJECTED ACCRUAL : A total 360 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose breast cancer , meet 1 follow criterion : Stage 0 disease ( ductal carcinoma situ ) Stage IIIIA disease Must meet 1 follow criterion : Diagnosis 50 year age Diagnosis 50 year age AND 1 following : First second degree relative diagnose breast cancer 50 year age First second degree relative diagnose ovarian cancer age First second degree relative diagnose male breast cancer age Must initiate definitive treatment breast cancer No bilateral , metastatic , inflammatory breast cancer No prior BRCA1/2 counsel test No prior diagnosis metastatic cancer type Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Sex Female Menopausal status Not specify Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Surgery No prior bilateral mastectomy breast cancer Other No concurrent treatment cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>breast cancer situ</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>